Practical approach to medical management of glaucoma.
作者信息
Bansal Atul, Fenerty Cecilia H
出版信息
Indian J Ophthalmol. 2009 Jan-Feb;57(1):75-6; author reply 76-7. doi: 10.4103/0301-4738.44506.
Abstract
摘要
相似文献
1
Practical approach to medical management of glaucoma.
Indian J Ophthalmol. 2009 Jan-Feb;57(1):75-6; author reply 76-7. doi: 10.4103/0301-4738.44506.
2
[Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
Vestn Oftalmol. 2005 Jul-Aug;121(4):41-3.
3
Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
Ophthalmology. 2005 Feb;112(2):267-71. doi: 10.1016/j.ophtha.2004.08.024.
4
Efficacy of latanoprost in management of chronic angle closure glaucoma.
Nepal J Ophthalmol. 2009 Jan-Jun;1(1):32-6. doi: 10.3126/nepjoph.v1i1.3671.
5
Comparison of the intraocular pressure-lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma: a preliminary study.
Ophthalmology. 2000 Jun;107(6):1178-83. doi: 10.1016/s0161-6420(00)00073-7.
6
Meta-analysis of the Efficacy and Safety of Latanoprost Monotherapy in Patients With Angle-closure Glaucoma.
J Glaucoma. 2016 Mar;25(3):e134-44. doi: 10.1097/IJG.0000000000000158.
7
Comparison of the effects of latanoprost and bimatoprost on intraocular pressure in chronic angle-closure glaucoma.
J Ocul Pharmacol Ther. 2007 Dec;23(6):559-66. doi: 10.1089/jop.2007.0037.
8
Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma.
J Ocul Pharmacol Ther. 2006 Dec;22(6):449-54. doi: 10.1089/jop.2006.22.449.
9
Efficacy of latanoprost in reducing intraocular pressure in patients with primary angle-closure glaucoma.
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S125-8. doi: 10.1016/s0039-6257(02)00305-3.
10
Meta-analysis of randomized controlled trials comparing latanoprost with other glaucoma medications in chronic angle-closure glaucoma.
Eur J Ophthalmol. 2015 Jan-Feb;25(1):18-26. doi: 10.5301/ejo.5000506. Epub 2014 Jul 8.
本文引用的文献
1
Practical approach to medical management of glaucoma.
Indian J Ophthalmol. 2008 May-Jun;56(3):223-30. doi: 10.4103/0301-4738.40362.
2
Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study.
J Ocul Pharmacol Ther. 2005 Feb;21(1):75-84. doi: 10.1089/jop.2005.21.75.
3
Degree of angle closure and the intraocular pressure-lowering effect of latanoprost in subjects with chronic angle-closure glaucoma.
Ophthalmology. 2005 Feb;112(2):267-71. doi: 10.1016/j.ophtha.2004.08.024.
4
Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma.
Arch Ophthalmol. 2004 Feb;122(2):185-9. doi: 10.1001/archopht.122.2.185.
5
Latanoprost and cholinergic agonists in combination.
Surv Ophthalmol. 2002 Aug;47 Suppl 1:S141-7. doi: 10.1016/s0039-6257(02)00309-0.
6
The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
Ophthalmology. 1999 Feb;106(2):386-90. doi: 10.1016/S0161-6420(99)90053-2.
Zotero 插件